SkyAI, Inc.

NASDAQ:STSS

Medical - Instruments & Supplies

Healthcare
$1.32 +0.00%

+$0.00 today

Market cap
$55.65M
Beta
2.02
P/E (TTM)
1.3
EPS (TTM)
$0.91
52W Low $1.09High $18.23

Volume 0.00M

Average 0.37M

STSS Research & Development

Spending on developing new products, technologies, and improvements to existing offerings.

SkyAI, Inc.NASDAQ: STSS

Research & Development · Q1 FY2026 · quarter ended Mar 2026

Research & development growth accelerates

Q1 FY2026 research & development of $137.1K rose 67.2% year over year, ahead of the -20.4% change in trailing-twelve-month research & development. Over 3 fiscal years it compounded at -50.4% a year.

Context

  • Research & development amounted to 97.4% of revenue in FY2025.
  • Research & development increased in 1 of the last 3 fiscal years.

What to watch

Whether quarterly growth of +67.2% holds above the trailing-twelve-month pace of -20.4%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$137.1K+538.3% QoQ
Last fiscal yearDec 2025
$198.76K+442.5% YoY
LTMMar 2026
$319.38K-20.4% YoY
Research & Development past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+67.2%——
1 year+442.5%——
3-year CAGR-50.4%——
5-year CAGR——
10-year CAGR——

Research & Development history

USD · from the income statement

Latest · FY2025
198.76K USD
Year-over-year change
+442.5%
4-year CAGR
-41.4%

Research & Development vs competitors

How STSS compares with its peers on the latest reported figures

  • STSS's LTM Mar 2026 research & development of $319.38K is the 9th highest of the 10 companies compared; the peer median is $7.56M.
  • Its year-over-year change of -20.4% is the 8th highest of 9, against a peer median of -8.6%.
  • Research & development amounts to 80.5% of revenue for STSS, versus a peer median of 38.8%.
STSS Competitors Peer median
Research & Development for STSS and competitors
Company Period LTM YoY 3-year CAGR% of revenue
CGTXCognition Therapeutics, Inc.LTM Mar 2026$32.45M -22.6%+7.0%—
GLSIGreenwich LifeSciences, Inc.LTM Mar 2026$15.76M +21.0%+38.5%—
RPIDRapid Micro Biosystems, Inc.LTM Mar 2026$13.34M -7.2%+1.9%38.8%
SERASera Prognostics, Inc.LTM Mar 2026$12.87M -10.5%-2.6%22573.7%
CCLDCareCloud, Inc.LTM Mar 2026$7.56M +84.3%+13.2%6.1%
MBOTMicrobot Medical Inc.LTM Mar 2026$6.11M -11.4%-6.7%5814.3%
LUCDLucid Diagnostics Inc.LTM Mar 2026$5.46M -7.8%+691.2%106.3%
PDEXPro-Dex, Inc.LTM Mar 2026$3.23M -9.4%+6.9%4.3%
STSSSkyAI, Inc.LTM Mar 2026$319.38K -20.4%-50.4%80.5%
JYNTThe Joint Corp.LTM Mar 2026$0 ——0.0%
Peer median (excluding STSS) $7.56M-8.6%+6.9%38.8%

Competitors are the stored peer set for STSS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue0000204.12K
Cost of Revenue28.7K654.57K891.25K773.9K617.45K
Gross Profit(28.7K)(654.57K)(891.25K)(773.9K)(413.33K)
Gross Margin————-202.5%
Research & Development1.69M1.63M729.48K(58.03K)198.76K
Selling, General & Admin2.78M6.45M8.52M7.14M19.49M
Operating Expenses4.47M8.08M9.24M7.08M12.88M
Depreciation & Amortization28.7K654.57K891.25K773.9K132.54K
EBITDA(4.47M)(2.66M)(8.98M)(6.85M)(269.74M)
EBITDA Margin————-132145.5%
Operating Income(4.5M)(8.74M)(10.13M)(7.86M)(13.29M)
Operating Margin————-6512.1%
Interest Income7691.32K138.12K40.3K0
Interest Expense167.52K1.32M01.71M416.66K
Other Income / Expenses(166.75K)4.1M255.01K(1.47M)(257.04M)
Income Before Tax(4.66M)(4.64M)(9.87M)(9.33M)(270.34M)
Pre-Tax Margin————-132439.5%
Income Tax Expense00(30K)(30K)0
Net Income(4.66M)(4.64M)(9.84M)(9.3M)(282.5M)
Net Margin————-138400.0%
EPS (Basic)(3,356.30)(3,780.28)(4,983.99)(2,220.05)(11.16)
EPS (Diluted)(3,356.30)(3,780.28)(4,983.99)(2,220.05)(11.16)
Weighted Avg Shares1.39K1.23K1.97K4.19K25.31M
Weighted Avg Shares (Diluted)1.39K1.23K1.97K4.19K25.31M

SkyAI, Inc.

NASDAQ:STSS

Intrinsic Alpha fair value

Locked

Current Price

$1.32

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.